Clinical Trial Update: A Phase I Trial of A-CAR032 in Participants With mCRPC [Phase 1]

View source ↗

Summary

The document details a Phase I clinical trial of A-CAR032 for metastatic castration-resistant prostate cancer, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• A-CAR032

Snippet

Sponsor: Shanghai AbelZeta Ltd. | Conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Status: RECRUITING